Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roberto Sorio

Showing results (1-10 of 60) with videos related to

Pageof 6
Sort By:
Tumori|May 7, 2002
Carboplatin in elderly patientsRoberto Sorio, Renata Talamini, Giuseppe Toffoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Carboplatin and topotecan combination and myelosuppressionGiuseppe Toffoli, Roberto Sorio, Franca Sartor, et al.
La Radiologia Medica|February 18, 2003
Abdominal recurrence of ovarian cancer: value of abdominal MR in patients with positive CA125 and negative CTLuca Balestreri, Lorenzo Bison, Roberto Sorio, et al.
Acta Oncologica (Stockholm, Sweden)|May 28, 2004
Vinorelbine-induced acute reversible peripheral neuropathy in a patient with ovarian carcinoma pretreated with carboplatin and paclitaxelSimona Scalone, Roberto Sorio, Roberto Bortolussi, et al.
Tumori|March 10, 2010
Incidence of palmar-plantar erythrodysesthesia in pretreated and unpretreated patients receiving pegylated liposomal doxorubicinGianMaria Miolo, Paolo Baldo, Ettore Bidoli, et al.
Plos One|February 24, 2018
A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of paclitaxel and 6α-hydroxy-paclitaxel in human plasma: Development, validation and application in a clinical pharmacokinetic studyBianca Posocco, Mauro Buzzo, Andrea Follegot, et al.
Oncology Letters|February 20, 2013
Paraneoplastic cerebellar degeneration associated with ovarian cancerAlessia Erika Russo, Simona Scalone, Giulia Costanza Leonardi, et al.
Cancers|July 2, 2021
Inhibition of CDK4/6 as Therapeutic Approach for Ovarian Cancer Patients: Current Evidences and Future PerspectivesAlessandra Dall'Acqua, Michele Bartoletti, Nastaran Masoudi-Khoram, et al.
Plos One|October 10, 2015
Prognostic Role of Serum Antibody Immunity to p53 Oncogenic Protein in Ovarian Cancer: A Systematic Review and a Meta-AnalysisMarica Garziera, Marcella Montico, Ettore Bidoli, et al.
International Journal of Oncology|March 17, 2009
Uterine cervical carcinoma: role of matrix metalloproteinases (review)Massimo Libra, Aurora Scalisi, Nadia Vella, et al.
Pageof 6

Showing results (1-10 of 60) with videos related to

Sort By:
Pageof 6
Tumori|May 7, 2002
Carboplatin in elderly patientsRoberto Sorio, Renata Talamini, Giuseppe Toffoli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 2002
Carboplatin and topotecan combination and myelosuppressionGiuseppe Toffoli, Roberto Sorio, Franca Sartor, et al.
La Radiologia Medica|February 18, 2003
Abdominal recurrence of ovarian cancer: value of abdominal MR in patients with positive CA125 and negative CTLuca Balestreri, Lorenzo Bison, Roberto Sorio, et al.
Acta Oncologica (Stockholm, Sweden)|May 28, 2004
Vinorelbine-induced acute reversible peripheral neuropathy in a patient with ovarian carcinoma pretreated with carboplatin and paclitaxelSimona Scalone, Roberto Sorio, Roberto Bortolussi, et al.
Tumori|March 10, 2010
Incidence of palmar-plantar erythrodysesthesia in pretreated and unpretreated patients receiving pegylated liposomal doxorubicinGianMaria Miolo, Paolo Baldo, Ettore Bidoli, et al.
Plos One|February 24, 2018
A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of paclitaxel and 6α-hydroxy-paclitaxel in human plasma: Development, validation and application in a clinical pharmacokinetic studyBianca Posocco, Mauro Buzzo, Andrea Follegot, et al.
Oncology Letters|February 20, 2013
Paraneoplastic cerebellar degeneration associated with ovarian cancerAlessia Erika Russo, Simona Scalone, Giulia Costanza Leonardi, et al.
Cancers|July 2, 2021
Inhibition of CDK4/6 as Therapeutic Approach for Ovarian Cancer Patients: Current Evidences and Future PerspectivesAlessandra Dall'Acqua, Michele Bartoletti, Nastaran Masoudi-Khoram, et al.
Plos One|October 10, 2015
Prognostic Role of Serum Antibody Immunity to p53 Oncogenic Protein in Ovarian Cancer: A Systematic Review and a Meta-AnalysisMarica Garziera, Marcella Montico, Ettore Bidoli, et al.
International Journal of Oncology|March 17, 2009
Uterine cervical carcinoma: role of matrix metalloproteinases (review)Massimo Libra, Aurora Scalisi, Nadia Vella, et al.
Pageof 6